Eton Pharmaceuticals 8-K Report: Key Insights for Investors - December 31, 2024
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Company Identification:
- Name: Eton Pharmaceuticals, Inc.
- CIK (Central Index Key): 0001710340
- IRS Employer Identification Number (EIN): 37-1858472
- Location: 21925 W. Field Parkway, Suite 235, Deer Park, IL 60010
- Phone Number: 847-787-7361
- Filing Details:
- Filing Type: 8-K (Current Report)
- Filing Date: December 31, 2024
- Period Covered: The financial data relates to the end of the fiscal year on December 31, 2024.
- Stock Information:
- Common Stock Symbol: ETON
- Exchange: NASDAQ
- Additional Metadata:
- Schema Reference: The filing references an XBRL schema file named "eton-20241231.xsd," indicating structured financial data.
Insights:
- The report is a current filing (8-K) which typically conveys significant events that shareholders should be aware of, indicating that Eton Pharmaceuticals may have important updates or announcements.
- As of the reporting date, the company is publicly traded on NASDAQ, which suggests it is subject to SEC regulations and scrutiny, providing some level of transparency and credibility to investors.
- The provided contact information shows a clear avenue for stakeholders to reach out for more information, which is a good practice for investor relations.
Further analysis would be required to understand the specific events or financial data detailed in the full 8-K filing.